Education
About Us
Working with TipRanks
Follow Us
Ultralife Corp. (ULBI)
NASDAQ:ULBI
Earnings Data
Report Date
Jul 24, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.13Last Year’s EPS
0.18Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 24, 2025
|% Change Since: 0.00%
|Next Earnings Date:Jul 24, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected mixed results with significant achievements such as the Electrochem acquisition and government/defense sales growth, but faced challenges including revenue decline in key segments and internal control weaknesses.Company Guidance
In the Ultralife Corporation's fourth-quarter 2024 earnings call, several key metrics and guidance for future performance were discussed. The company reported Q4 sales of $43.9 million, with an operating income of $1.5 million and an EPS of $0.01, influenced by $1.1 million in one-time costs from the Electrochem acquisition. For the full year, sales reached $164.5 million, with an operating income of $10 million and an EPS of $0.38. The company noted a 48.1% increase in government/defense sales, offset by a 47.2% decline in medical battery sales. Gross profit was $10.6 million, with a margin of 24.2%, down from 25.6% in the previous year. The backlog stood at $102.2 million, representing 62% of TTM sales. Looking ahead to 2025, the company emphasized leveraging its recent acquisition of Electrochem Solutions, improving internal processes, and expanding its sales funnel to support growth, with expectations of realizing significant synergies and market expansion in both the Battery & Energy and Communications Systems segments.Electrochem Acquisition
Completed the largest strategic acquisition to date of Electrochem Solutions, which adds vertical integration capability to the oil and gas business, offers expansion opportunities in emission-critical markets, and creates material cost synergies.
Government/Defense Sales Increase
Government/defense sales increased by 48.1%, indicating strong demand for US government defense products.
Material Cost Deflation Wins
Negotiated down pricing on key components such as lithium foil and electrolytes, and signed a long-term supply agreement with a major customer, enhancing supply chain efficiency.
Employee Retention Credit Approval
The IRS approved a $1.5 million employee retention credit, providing additional funds to reduce acquisition debt.
Product Development and Pipeline Growth
Significant progress in product development across various segments, including a new amplification product, enhancements in thionyl chloride products, and a thin cell for medical wearables with expected production orders by mid-year 2025.
---
ULBI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ULBI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 24, 2025 | $4.44 | $4.58 | +3.15% |
| Apr 01, 2025 | $5.38 | $5.05 | -6.13% |
| Nov 08, 2024 | $9.28 | $7.98 | -14.01% |
| Jul 25, 2024 | $11.37 | $10.91 | -4.05% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Ultralife Corp. (ULBI) report earnings?
Ultralife Corp. (ULBI) is schdueled to report earning on Jul 24, 2025, TBA Not Confirmed.
What is Ultralife Corp. (ULBI) earnings time?
Ultralife Corp. (ULBI) earnings time is at Jul 24, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ULBI EPS forecast?
ULBI EPS forecast for the fiscal quarter 2025 (Q2) is 0.13.
---